Methods of pharmaceutical treatment comprising orally administering to a human subject having Crohns disease or ulcerative colitis a therapeutic composition once per day in the evening or at bedtime, wherein the composition comprises about 3 mg to about 4.5 mg of naltrexone, nalmefene, naloxone, or a hydrochloride salt thereof, in an immediate release solid dosage formulation, are disclosed.